BEIJING (Reuters) – China has expanded a pilot drug bulk-buying program to almost the entire country in an attempt to negotiate lower prices from drug manufacturers, heaping fresh pressure on multinational pharmaceutical companies and their domestic rivals. The program rolled out last year saw 11 Chinese cities, including Beijing and Shanghai, band together behind a… Read More »
Christopher Holmes has haemophilia A – his body lacks a protein that makes blood clot. A simple graze can mean the two-year-old bleeds uncontrollably. To avoid this he needs treatment every few days with a drug put into his bloodstream via a tube in his chest. But now, NHS England has agreed to fund a… Read More »
Broadly defined, precision medicine is about the personalization of care. Yet on a practical level, precision medicine can take on different forms in different subspecialties in healthcare. In modern oncology care, it’s largely about getting the right drugs to the right patient at the right time. There’s also some early evidence that more efficient targeted… Read More »
Puma Biotech has only retained commercial rights to its cancer drug Nerlynx in the U.S. and Japan after a series of licensing deals. But even the remaining U.S. launch doesn’t seem to be going well. In the first quarter, Nerlynx ginned up sales of $ 45.6 million, Puma said Thursday. That’s way below analyst expectations of… Read More »